The present invention relates to an activated sludge wastewater treatment process. More particularly, the invention relates to the removal of inert solids from a low-yield wastewater treatment process.
Wastewater pollutants are typically classified as either organic pollutants or inorganic pollutants. Organic pollutants generally refer to those substances that contain carbon and can be burned. Organic pollutants are often removed by biological wastewater treatment, that is, by cultivating bacteria to convert most of the organic pollutants in the wastewater to carbon dioxide, water, and biomass. Any biomass produced in the process is then separated from the treated wastewater and disposed of by various means, such as landfilling, incineration or application to topsoil as fertilizer. There also exists a class of organic pollutants which are refractory, that is, slow or difficult to biodegrade. Some well-known examples include plastics and hair.
Inorganic pollutants are generally not biologically degradable. Inorganic pollutants are often referred to as minerals. Some well-known examples include clays, grit and sand. In a conventional wastewater treatment plant, inorganic pollutants must be removed from the plant, or they will accumulate in the processing tanks, diminishing the actual volume within the tanks available for biological treatment. For the purposes of this disclosure, inorganic pollutants and refractory organic pollutants will be referred to as “inert solids.” Biologically degradable organic pollutants will be referred to as “readily degradable solids.”
A conventional activated sludge wastewater treatment process is shown in
In general, the proportion of inert solids to readily degradable solids in WAS is similar to that in the mixed liquor in the aeration reactor. In a traditional activated sludge plant, the WAS flow rate is high enough that the concentration of inert solids accumulated within the wastewater treatment plant is relatively low. However, newer processes have been designed that minimize the production of biosludge. These low-yield (low-biosludge-production) wastewater treatment processes significantly reduce WAS, limiting the rate at which inert solids are removed from a plant. Since WAS has typically been the only pathway by which inert solids are removed from a wastewater treatment plant, it follows that inert solids will accumulate within a low-yield wastewater treatment plant unless the inert solids are removed by some other means.
In one embodiment, the invention provides a wastewater treatment method comprising combining wastewater comprising readily degradable solids and inert solids with bacteria-laden sludge in a mainstream reactor to form a mixed liquor, separating the mixed liquor into a clarified effluent and an activated sludge, passing a first portion of activated sludge through a screening device to remove at least a portion of the inert solids and returning the screened first portion of activated sludge to the mainstream reactor, and treating a second portion of activated sludge in a sidestream bioreactor prior to returning the second portion of activated sludge to the mainstream reactor.
In another embodiment the invention provides a wastewater treatment method comprising combining wastewater comprising readily degradable solids and inert solids with bacteria-laden sludge in a mainstream reactor to form a mixed liquor, separating the mixed liquor into a clarified effluent and an activated sludge, returning a first portion of activated sludge to the mainstream reactor through one of a screening device that removes at least a portion of the inert solids from the activated sludge, a screen bypass line that discharges activated sludge directly into the mainstream reactor, or a combination of both, and treating a second portion of activated sludge in a sidestream bioreactor prior to returning the second portion of activated sludge to the mainstream reactor.
In a further embodiment, the invention provides a wastewater treatment method comprising combining wastewater comprising readily degradable solids and inert solids with bacteria-laden sludge in a mainstream reactor to form a mixed liquor, separating the mixed liquor into a clarified effluent and an activated sludge, passing a first portion of activated sludge through a rotary drum to remove at least a portion of the inert solids and returning the screened first portion of activated sludge to the mainstream reactor, and treating a second portion of activated sludge in a sidestream bioreactor prior to returning the second portion of activated sludge to the mainstream reactor.
In yet a further embodiment, the invention provides a wastewater treatment method comprising combining wastewater comprising readily degradable solids and inert solids with bacteria laden sludge in a mainstream reactor to form a mixed liquor, passing at least a portion of the mixed liquor through a screening device to remove at least a portion of the inert solids, separating the screened mixed liquor into a clarified effluent and an activated sludge, recycling a first portion of activated sludge to the mainstream reactor, and treating a second portion of activated sludge in a sidestream bioreactor prior to returning the second portion of activated sludge to the mainstream reactor.
In still another embodiment, the invention provides a wastewater treatment method comprising combining wastewater comprising readily degradable solids and inert solids with bacteria-laden sludge in a mainstream reactor to form a mixed liquor, separating the mixed liquor into a clarified effluent and an activated sludge, and passing at least a portion of activated sludge through a screening device having screen openings from about 10 μm to about 2,500 μm to remove at least a portion of the inert solids and returning the screened portion of activated sludge to the mainstream reactor, wherein the wastewater treatment method is a low-yield process.
Other aspects of the invention will become apparent by consideration of the detailed description and accompanying drawings.
Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the term “mounted” and variations thereof are used broadly and encompass both direct and indirect mountings. The word “conduit” is used broadly to represent a pathway, and is not meant to be restricted to any particular physical or mechanical device.
The invention discloses low-yield wastewater treatment processes comprising a sidestream bioreactor and a means for removing inert solids. The invention is particularly suited to wastewater treatment plants having a significant influx of inert solids.
As shown in
The biological populations within the mainstream reactor 10 can be adjusted to accommodate seasonal variations in wastewater and/or treat specific pollutants by varying the number and sequence of reactor zones. The mainstream reactor 10 can be divided into a finite number of discrete zones defined by distinct boundaries. In one embodiment, the mainstream reactor 10 includes three reactor zones, where the mixed liquor is first subjected to an aerobic zone, then subjected to an anoxic zone, and finally subjected to an aerobic zone. In another embodiment, the mainstream reactor 10 includes two reactor zones, where the mixed liquor is first subjected to an aerobic zone followed by an anaerobic zone. In a further embodiment, the mainstream reactor 10 includes four reactor zones, where the mixed liquor is first subjected to an anaerobic zone, followed by an anoxic zone and two aerobic zones. The listed embodiments serve only as examples. It should be understood that the mainstream reactor 10 can comprise two or more reactor zones arranged in any sequence. Furthermore, the mainstream reactor 10 can run as a batch process or a continuous process.
The mainstream reactor 10 can also have a long plug flow design where there are no discrete boundaries and the conditions change gradually over the length of the tank. In one embodiment, the tank environment gradually transitions from an aerobic environment in the upstream end to an anoxic environment in the downstream end. In an alternative embodiment, the tank environment gradually transitions from an anaerobic environment in the upstream end, to an anoxic environment in the middle, and to an aerobic environment in the downstream end.
From the mainstream reactor 10, the mixed liquor is transferred by conduit 18 to a solid-liquid separator 20 where solids are separated from the mixed liquor, leaving behind an activated sludge and a clarified effluent. In the embodiment shown in
The solid-liquid separator 20 is any device that separates solids from liquids by, for example, gravity, differential settling velocity, or size-exclusion. Examples of solid-liquid separators include settling ponds, clarifiers, hydrocyclones, centrifuges, and membrane filters or separators. The clear effluent is removed by conduit 22 and can be disinfected and then discharged into a local waterway. The remaining activated sludge comprises live bacteria, expired bacteria, and inert solids.
A portion of the activated sludge from the solid-liquid separator 20 is recycled to the mainstream reactor 10 by conduits 24 and 26. The recycled sludge, also known as return activated sludge (RAS), maintains a sufficient concentration of bacterial cells in the mainstream reactor 10 to effectively treat the incoming wastewater. A portion of the activated sludge may also be transferred directly by conduit 28, and/or indirectly by conduits 24, 25 and 28, to the sidestream bioreactor 12 where a second bacteria population is cultivated under one or more growth conditions to facilitate the decomposition of readily degradable solids in the wastewater treatment process. A suitable sidestream bioreactor 12 is described below and in U.S. Pat. No. 6,660,163 issued to Miklos, which is hereby fully incorporated by reference.
The bacteria population within the activated sludge typically comprises one or more classes of bacteria. Such classes of bacteria include, but are not limited to, obligate aerobes, facultative aerobes, nitrifiers, obligate anaerobes, and facultative anaerobes. Each bacteria performs a certain function. For example, some bacteria convert particulate biochemical oxygen demand (BOD) into soluble BOD for utilization, some reduce high solids yield organisms, and some improve nitrification/denitrification efficiency. Each bacteria also thrives within a particular range of conditions. Aerobic bacteria thrive in an oxygen-rich environment, anaerobic bacteria thrive in an oxygen-depleted environment, and facultative bacteria can thrive in both environments. Bacteria within a population may be selectively activated by changing the growth conditions to which the population is subjected. Desired growth conditions may be achieved by effecting a selected order of aerobic, anoxic, and anaerobic conditions for varied lengths of time and repetitively controlling those conditions by measurement and reproduction of the oxidation-reduction potential (ORP), specific oxygen uptake rate (SOUR), and/or specific nitrogen uptake rate (SNUR). Therefore, within the sidestream bioreactor 12 it is possible to treat more than one component in the wastewater by selectively varying the conditions of the sidestream bioreactor 12 to sequentially activate the individual types of bacteria.
In one embodiment, the sidestream bioreactor 12 is run under anaerobic conditions to promote the growth and activity of anaerobic bacteria. Such bacteria can include obligate anaerobes and/or facultative anaerobes. Under anaerobic conditions, the bacteria that accumulated quantities of phosphorus in excess of that required for simple cell growth and reproduction during aeration, now take up and store simple carbon compounds, using energy derived from the hydrolysis and release of phosphates. When the activated sludge is eventually returned to the mainstream reactor 10, these bacteria are able to metabolize the absorbed carbon compounds in an aerobic zone.
In a second embodiment, the sidestream bioreactor 12 is a sequencing facultative digester (SFD) favoring a low solids yield. Within an SFD, the activated sludge comprising facultative bacteria is subjected to a sequence of anaerobic and anoxic conditions that contribute to breaking down the readily degradable solids in the wastewater treatment process. The SFD can operate as a batch process, where the entire contents of the SFD are under anoxic conditions or anaerobic conditions at a single moment. Alternatively, the SFD can operate as a continuous process where the SFD is divided into separate compartments, each compartment operating under anoxic or anaerobic conditions. The sequence of conditions may take any order. After processing in the sidestream bioreactor 12, the activated sludge may be recycled to the mainstream reactor 10 as interchange activated sludge (IAS) by conduit 30.
Although each of the activated sludge pathways has been described individually, it should be recognized that the activated sludge may be entirely diverted along one of the pathways or alternatively split along both pathways. Additionally, the selected pathways and the amount of the activated sludge sent to each pathway may be adjusted as needed to most efficiently and effectively treat the wastewater entering the treatment plant at any given time. In one embodiment, about 90% of the activated sludge from the solid-liquid separator 20 is recycled to the mainstream reactor 10 and about 10% of the activated sludge from the solid-liquid separator 20 is passed through the sidestream bioreactor 12. In an additional embodiment, about 80% of the activated sludge from the solid-liquid separator 20 is recycled to the mainstream reactor 10 and about 20% of the activated sludge from the solid-liquid separator 20 is passed through the sidestream bioreactor 12.
The RAS recycled to the mainstream reactor 10 is passed through a screening device 14 to remove inert solids. As shown in
The screening device 14 may comprise any screen or media filter having the capability of filtering inert solids from a wastewater stream while allowing the majority of the bacterial cell mass to pass through. Hereinafter, screens and media filters may be used interchangeably when describing the screening device 14. Screen openings (or interstitial spaces in the case of media filters) are typically at least about 10 μm, more particularly at least about 150 μm, and even more particularly at least about 250 μm. Screen openings are typically smaller than about 6,000 μm, more particularly smaller than about 2,500 μm, and even more particularly smaller than about 500 μm. This includes embodiments having screen openings in the range of about 10 μm to about 6,000 μm, further includes embodiments having screen openings in the range of about 10 μm to about 2,500 μm, and still further includes embodiments having screen openings in the range of about 250 μm to about 500 μm. In one embodiment, the screening device removes inert solids having average particle diameters greater than 100 μm. In another embodiment, the screening device removes inert solids having average particle diameters greater than about 50 μm.
Although screens are particularly efficient at removing pollutants having average particle diameters greater than the screen openings, it has also been found that screens can capture fine particles which are substantially smaller than the screen openings. The larger particles can form a “mat” or coating which partially blocks the screen openings, effectively reducing their size. Therefore, the screening device 14 may remove a significant number of pollutants having particle dimensions less than the size of the screen openings. In some embodiments, the screening device 14 having a screen opening size of greater than about 100 μm may remove inert solids having average particle diameters smaller than about 100 μm. In other embodiments, the screening device 14 having a screen opening size of greater than about 50 μm may remove inert solids having average particle diameters smaller than about 50 μm.
Suitable screening devices 14 may comprise drum screens. Drum screens may include mesh screening elements. More preferably, the drum screens include wedgewire screening elements. Suitable commercial screening devices include, but are not limited to, BU Milliscreen from Contra Shear™ (Aukland, New Zealand), Rotoscreen™ Escalating Fine Channel Screen from Parkson Corporation (Fort Lauderdale, Fla.), Hycor® Rotoshear® also from Parkson Corporation, Huber Brand Screens (Wiltshire SN14 6NQ, United Kingdom), and a modified Microscreen™ drum screen which may use modular panels of molded plastic mesh from USFilter (Waukesha, Wis.). Other suitable screening devices 14 may include media filters, such as sand filters.
It should be recognized by one skilled in the art that the screening device 14 may comprise a single screen or multiple screens arranged in series or parallel. Multiple screens within a single screening device 14 may have the same size openings, different size openings, or combinations thereof. The screening device 14 may be positioned at various locations throughout the treatment plant. In the embodiment represented by
Although the screening device removes a significant portion of inert solids in a wastewater stream, it does not remove 100% of the inert solids. As a result, inert solids may build up in the processing tanks over time. Therefore, conduit 33 provides a means for periodic wasting of the sludge to prevent the build-up of inert solids in the wastewater treatment system. The period between sludge wasting will depend upon a number of factors that include, but are not limited to, the nature of the incoming wastewater, the treatment process and the time of year. For example, a wastewater treatment plant may waste sludge every month, every six months or once a year. Additionally, a wastewater treatment plant may waste all of the sludge or just a portion of the sludge at any given time. Although the location of wasting in
It should be recognized by those skilled in the art that the screening device 14 may be located at positions in the treatment process not exemplified in the above embodiments. For example, in one embodiment, the screening device 14 may treat incoming wastewater at a location upstream of the mainstream reactor 10. In other embodiments, multiple screening devices may be located at more than one site within the wastewater treatment process.
The flow rate through the screening device 14 may vary but is typically about 5% to about 400% of the influent flow rate. For example, in a conventional treatment plant having a clarifier as a solid-liquid separator, the RAS rate may be about 25% to about 150% of the influent flow rate to the treatment plant, and the screen flow rate may be about 25% to about 100% of the RAS rate. In a treatment plant having a membrane as a solid-liquid separator, the screening rate may be greater than 100% of the influent flow rate to the plant. The flow rate may be substantially continuous; however, periodic interruptions in flow rate may be tolerated without a significant impact on performance. For example, the flow rate may be temporarily suspended to clean inert solids from the screening device 14. Methods of removing inert solids from the screening device 14 are well-known to those skilled in the art and typically vary with the type of screening device 14 employed.
In a representative implementation, a Contra Shear™ Model #20/40U wedgewire drum screen having a compactor at the discharge end was installed in the RAS pathway of a low-yield wastewater treatment process. The nominal wedgewire opening width was 250 μm, although actual measurements with a dial caliper gave values ranging from 200 μm to 400 μm. RAS upstream of the drum screen was found to have 14,700 mg/l total suspended solids (TSS) and 10,375 mg/l volatile suspended solids (VSS). RAS immediately downstream of the drum screen was found to have 13,100 mg/l TSS and 9,228 mg/l VSS. Screenings sent to the compactor were found to have 11% total solids (TS) and 86% volatile solids (VS). Screenings exiting the compactor were found to have 26% TS of which 88% was VS. When a sample of the screenings sent to the compactor where dropped into a graduated cylinder containing water, most of the sample sank to the bottom of the cylinder, suggesting most solids in the screenings were denser than water. However, it was observed that a significant amount of the screenings appeared to have a specific gravity near that of water.
Thus, the invention provides, among other things, a low-yield wastewater treatment process comprising a sidestream bioreactor and a screening device for removing inert solids. Various features and advantages of the invention are set forth in the following claims.
This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Patent Application No. 60/713,804 filed Sep. 2, 2005, the entire content of which is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2893957 | Genter et al. | Jul 1959 | A |
3047492 | Gambrel | Jul 1962 | A |
3192155 | Bready et al. | Jun 1965 | A |
3259566 | Torpey | Jul 1966 | A |
3544476 | Aiba et al. | Dec 1970 | A |
3617540 | Bishop et al. | Nov 1971 | A |
3756946 | Levin et al. | Sep 1973 | A |
3787316 | Brink et al. | Jan 1974 | A |
3907672 | Milne | Sep 1975 | A |
3964998 | Barnard | Jun 1976 | A |
4042493 | Matsch et al. | Aug 1977 | A |
4056465 | Spector | Nov 1977 | A |
4132638 | Carlsson | Jan 1979 | A |
4141822 | Levin et al. | Feb 1979 | A |
4160724 | Laughton | Jul 1979 | A |
4162153 | Spector | Jul 1979 | A |
4173531 | Matsch et al. | Nov 1979 | A |
4271026 | Chen et al. | Jun 1981 | A |
4277342 | Hayes et al. | Jul 1981 | A |
4279753 | Nielson et al. | Jul 1981 | A |
4284510 | Savard et al. | Aug 1981 | A |
4323367 | Ghosh | Apr 1982 | A |
4351729 | Witt | Sep 1982 | A |
4370233 | Hayes et al. | Jan 1983 | A |
4374730 | Braha et al. | Feb 1983 | A |
4407717 | Teletzke et al. | Oct 1983 | A |
4491522 | Ishida et al. | Jan 1985 | A |
4522722 | Nicholas | Jun 1985 | A |
4527947 | Elliot | Jul 1985 | A |
4537682 | Wong-Chong | Aug 1985 | A |
4568457 | Sullivan | Feb 1986 | A |
4568462 | Böhnke et al. | Feb 1986 | A |
4599167 | Benjes et al. | Jul 1986 | A |
4632758 | Whittle | Dec 1986 | A |
4643830 | Reid | Feb 1987 | A |
RE32429 | Spector | Jun 1987 | E |
4675114 | Zagyvai et al. | Jun 1987 | A |
4705633 | Bogusch | Nov 1987 | A |
4731185 | Chen et al. | Mar 1988 | A |
4780198 | Crawford et al. | Oct 1988 | A |
4790939 | Suzuki et al. | Dec 1988 | A |
4797212 | Von Nordenskjöld | Jan 1989 | A |
4818391 | Love | Apr 1989 | A |
4842732 | Tharp | Jun 1989 | A |
4849108 | De Wilde et al. | Jul 1989 | A |
4867883 | Daigger et al. | Sep 1989 | A |
4874519 | Williamson | Oct 1989 | A |
4891136 | Voyt | Jan 1990 | A |
4915840 | Rozich | Apr 1990 | A |
4956094 | Levin et al. | Sep 1990 | A |
4961854 | Wittmann et al. | Oct 1990 | A |
4975197 | Wittmann et al. | Dec 1990 | A |
4999111 | Williamson | Mar 1991 | A |
5013442 | Davis et al. | May 1991 | A |
5019266 | Soeder et al. | May 1991 | A |
5022993 | Williamson | Jun 1991 | A |
5051191 | Rasmussen et al. | Sep 1991 | A |
5094752 | Davis et al. | Mar 1992 | A |
5098567 | Nishiguchi | Mar 1992 | A |
5114587 | Hagerstedt | May 1992 | A |
5126049 | Hallberg | Jun 1992 | A |
5128040 | Molof et al. | Jul 1992 | A |
5137636 | Bundgaard | Aug 1992 | A |
5151187 | Behmann | Sep 1992 | A |
5182021 | Spector | Jan 1993 | A |
5234595 | DiGregorio et al. | Aug 1993 | A |
5246585 | Meiring | Sep 1993 | A |
5254253 | Behmann | Oct 1993 | A |
5288405 | Lamb, III | Feb 1994 | A |
5288406 | Stein | Feb 1994 | A |
5304308 | Tsumura et al. | Apr 1994 | A |
5316682 | Keyser et al. | May 1994 | A |
5336290 | Jermstad | Aug 1994 | A |
5342522 | Marsman et al. | Aug 1994 | A |
5348653 | Rovel | Sep 1994 | A |
5348655 | Simas et al. | Sep 1994 | A |
5356537 | Thurmond et al. | Oct 1994 | A |
5376242 | Hayakawa | Dec 1994 | A |
5380438 | Nungesser | Jan 1995 | A |
5389258 | Smis et al. | Feb 1995 | A |
5480548 | Daigger et al. | Jan 1996 | A |
5482630 | Lee et al. | Jan 1996 | A |
5505862 | Sonnenrein | Apr 1996 | A |
5514277 | Khudenko | May 1996 | A |
5514278 | Khudenko | May 1996 | A |
5531896 | Tambo et al. | Jul 1996 | A |
5543051 | Harris | Aug 1996 | A |
5543063 | Walker et al. | Aug 1996 | A |
5582734 | Coleman et al. | Dec 1996 | A |
5601719 | Hawkins et al. | Feb 1997 | A |
5611927 | Schmid | Mar 1997 | A |
5624562 | Scroggins | Apr 1997 | A |
5624565 | Lefevre et al. | Apr 1997 | A |
5626755 | Keyser et al. | May 1997 | A |
5650069 | Hong et al. | Jul 1997 | A |
5651891 | Molof et al. | Jul 1997 | A |
5658458 | Keyser et al. | Aug 1997 | A |
5725772 | Shirodkar | Mar 1998 | A |
5733455 | Molof et al. | Mar 1998 | A |
5733456 | Okey et al. | Mar 1998 | A |
5746919 | Dague et al. | May 1998 | A |
5773526 | Van Dijk et al. | Jun 1998 | A |
5811008 | Von Nordenskjold | Sep 1998 | A |
5818412 | Maekawa | Oct 1998 | A |
5824222 | Keyser et al. | Oct 1998 | A |
5833856 | Liu et al. | Nov 1998 | A |
5846424 | Khudenko | Dec 1998 | A |
5853588 | Molof et al. | Dec 1998 | A |
5858222 | Shibata et al. | Jan 1999 | A |
5919367 | Khudenko | Jul 1999 | A |
5989428 | Goronszy | Nov 1999 | A |
5993503 | Kruidhof | Nov 1999 | A |
6004463 | Swett | Dec 1999 | A |
6015496 | Khudenko | Jan 2000 | A |
6036862 | Stover | Mar 2000 | A |
6039874 | Teran et al. | Mar 2000 | A |
6047768 | Buehler, III | Apr 2000 | A |
6054044 | Hoffland et al. | Apr 2000 | A |
6066256 | Henry et al. | May 2000 | A |
6077430 | Chudoba et al. | Jun 2000 | A |
6113788 | Molof et al. | Sep 2000 | A |
6117323 | Haggerty | Sep 2000 | A |
6193889 | Teran et al. | Feb 2001 | B1 |
6217768 | Hansen et al. | Apr 2001 | B1 |
6352643 | Kwon et al. | Mar 2002 | B1 |
6383387 | Hasegawa et al. | May 2002 | B2 |
6416668 | Al-Samadi | Jul 2002 | B1 |
6454949 | Sesay et al. | Sep 2002 | B1 |
6527956 | Lefevre et al. | Mar 2003 | B1 |
6555002 | Garcia et al. | Apr 2003 | B2 |
6562237 | Olaopa | May 2003 | B1 |
6585895 | Smith et al. | Jul 2003 | B2 |
6592762 | Smith | Jul 2003 | B2 |
6605220 | Garcia et al. | Aug 2003 | B2 |
6613238 | Schloss | Sep 2003 | B2 |
6630067 | Shieh et al. | Oct 2003 | B2 |
6660163 | Miklos | Dec 2003 | B2 |
6706185 | Goel et al. | Mar 2004 | B2 |
6712970 | Trivedi | Mar 2004 | B1 |
6783679 | Rozich | Aug 2004 | B1 |
6787035 | Wang | Sep 2004 | B2 |
6805806 | Arnaud | Oct 2004 | B2 |
6814868 | Phagoo et al. | Nov 2004 | B2 |
6833074 | Miklos | Dec 2004 | B2 |
6863818 | Daigger et al. | Mar 2005 | B2 |
6884355 | Kamiya et al. | Apr 2005 | B2 |
6893567 | Vanotti et al. | May 2005 | B1 |
7105091 | Miklos | Sep 2006 | B2 |
7208090 | Applegate et al. | Apr 2007 | B2 |
20010045390 | Kim et al. | Nov 2001 | A1 |
20040016698 | Unger | Jan 2004 | A1 |
20050040103 | Abu-Orf et al. | Feb 2005 | A1 |
20050045557 | Daigger et al. | Mar 2005 | A1 |
20060113243 | Applegate et al. | Jun 2006 | A1 |
20070000836 | Elefritz et al. | Jan 2007 | A1 |
Number | Date | Country |
---|---|---|
4 238 708 | May 1994 | DE |
4444335 | Jun 1996 | DE |
0 106 043 | Apr 1984 | EP |
0 408 878 | Jan 1991 | EP |
0 440 996 | Aug 1991 | EP |
1 236 686 | Sep 2002 | EP |
2 006 743 | May 1979 | GB |
59032999 | Feb 1984 | JP |
59052597 | Mar 1984 | JP |
60-84199 | May 1985 | JP |
61192389 | Aug 1986 | JP |
63130197 | Jun 1988 | JP |
62138986 | Dec 1988 | JP |
63302996 | Dec 1988 | JP |
01174949 | Feb 1991 | JP |
3042019 | Feb 1991 | JP |
6091285 | Apr 1994 | JP |
P2000-199086 | Jul 2000 | JP |
2000210542 | Aug 2000 | JP |
9301791 | Oct 1993 | NL |
1 596 752 | Sep 1995 | RU |
WO 9315026 | Aug 1993 | WO |
WO 9424055 | Oct 1994 | WO |
WO 03072512 | Sep 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20070051677 A1 | Mar 2007 | US |
Number | Date | Country | |
---|---|---|---|
60713804 | Sep 2005 | US |